Jeito Capital
Fiche investisseur | Builders Republic
À propos
Jeito Capital is a leading venture capital firm dedicated to the biopharma sector. Founded by Dr. Rafaèle Tordjman (MD, PhD), Jeito stands out with a "patient benefit" driven approach. Unlike typical VCs that might exit early, Jeito operates on a model of "continuity," providing massive capital support from early clinical stages all the way to market access and commercialization. Their goal is to build the next generation of market leaders in medical innovation without them having to sell out too early to big pharma.
Informations clés
- Type
- Venture Capital
- Stades
- Series A,Series B,Growth
- Secteurs
- Biotech
- Siège
- France
- Bureaux
- Paris
- Focus géographique
- France,Europe,USA
- Lead / Follow
- Lead / co-lead
- Ticket
- 10M€ – 50M€
- Actifs sous gestion
- 534M€
- Fondé en
- 2018
Track Record
- Sociétés en portefeuille : 20
- Investissements totaux : 29
- Exits : 3
Investissements notables en France
Sparing Vision, Alentis Therapeutics, Eye Bio, Catalym
Points différenciants
Sector Specialist,Strong Track Record,Women-Led